1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Silo Wellness Inc.

Silo Wellness Inc.

SILO.CN
Silo Wellness Inc.CA flagCanadian Securities Exchange
0.01
CAD
- -
- -
1.54MMarket Cap
Silo Wellness Inc.
SILO.CN
(Canadian Securities Exchange)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
TTM
FRC
- -
0.04
0.05
- -
Revenue per Share
-0.44
-2
-0.87
0.01
Basic EPS, GAAP
-0.2
-1.23
-0.08
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
-0.01
-0.7
-1.09
-0.03
Book Value per Share
-0.03
-0.12
-0.8
-0.02
Tangible Book Value per Share
3
3
7
97
Basic Weighted Avg Shares
- -
- -
- -
- -
Sales/Revenue/Turnover
-22,340.77
-4,153.6
-1,491.09
-1,341.6
Operating Margin (%)
- -
- -
- -
- -
Depreciation Expense
-1
-6
-6
1
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
-22,277.56
-5,168.9
-1,730.85
184.04
Profit Margin (%)
- -
- -
-5
-2
Working Capital
- -
- -
- -
- -
LT Debt
- -
- -
-5
-2
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
-20.78
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jan'23
Apr'23
Jul'23
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
143
154
Market Capitalization
- -
1
1

Working Capital

FRC

•

in mil. unless spec.
Jan'23
Apr'23
Jul'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
2
2
Payables & Accruals
5
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
1,377.58%
Free Cash Flow
- -
- -
-86.18%
Net Income, GAAP
- -
- -
-6.39%
Sales/Revenue/Turnover
- -
- -
179.56%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.02
-1.28
-0.38
- -
-2
2022
-0.2
-0.36
-0.42
- -
-0.87
2023
-0.01
0.03
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
MJardin Group, Inc. (MJARF)
Cannara Biotech Inc. (LOVE.TO)
China Medical System Holdings Limited (0867.HK)
Vinergy Capital Inc. (VIN.CN)
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS)
Aleafia Health Inc. (ALEAF)
Business
Silo Wellness Inc. (CSE: SILO) operates as a psychedelics and wellness company focused on mental health treatments through psilocybin-based therapies and retreats; it offers guided psilocybin healing retreats in Jamaica featuring precise dosing, professional support, integration services, beachside accommodations, ital-focused meals, and two ceremonial sessions; develops psilocybin nasal spray for controlled micro-dosing and psilocybin-free functional mushroom tinctures; and provides psychedelic wellness experiences including cultivation in Jamaica and planned service centers in Oregon. The company targets individuals seeking trauma reduction, personal growth, and mental health improvement, with operations in Jamaica, Oregon, and Canada. Founded in 2018 by Oregon trial lawyer Mike Arnold and headquartered in Toronto, Ontario at 200 Consumers Road Suite 702, Silo Wellness maintains intellectual property rights in psychedelic formulations and previously pursued retail outlets for functional mushrooms. In a major strategic shift announced in 2025, the company proposes to change its name to Born Defense Inc. and pivot its business to defense innovation and national security investments aligned with Just War Doctrine principles, including cybersecurity, autonomous systems, and advanced manufacturing; it submitted a CSE listing statement on September 26, 2025, to support relisting under the new focus while settling CAD $4.4 million in debt via share issuance. Recent activities include a 2023 strategic partnership and LOI with NUGL Inc. (Kaya Group) for Jamaican psychedelic retreats valued at CAD $43.3 million, though later extended and impacted by market conditions; terminated BitGift asset acquisition in 2023; and prepaid for Oregon psilocybin mushrooms under a right of first refusal. Silo Wellness, formerly Yukoterre Resources Inc., positions for growth amid regulatory challenges in psychedelics by transitioning to high-demand defense sectors with global market potential exceeding $600 billion by 2029.